BrainsWay Deep TMS

10/10/2025

🌍 Today is World Mental Health Day.

Mental health is an essential part of overall well-being, and everyone deserves access to care and support. At BrainsWay, we are dedicated to expanding treatment options and helping more people find hope and healing. 💙💚

Let’s keep the conversation open, reduce stigma, and support each other.

10/06/2025

It's OCD Awareness Month! Did you know there are 5 effective strategies for treating OCD?

In addition to medication, therapy and lifestyle changes, people with OCD may also benefit from ™.

10/02/2025

Expanding Access to Breakthrough Mental Health Care in Chester County

We’re excited to welcome MooreWays to Mental Health in Exton’s Eagleview community as the newest member of the BrainsWay network. By offering Deep TMS™, MooreWays is helping bring cutting-edge, non-invasive mental health care to more people across the region.

We’re proud to see Deep TMS reaching more communities and transforming more lives, one clinic and one patient at a time.

https://vista.today/2025/09/mooreways-deep-transcranial-magnetic-stimulation/

09/30/2025

🌎 BrainsWay at AAP 2025

Last week, BrainsWay had the pleasure of participating in the Argentinian Association for Psychiatry (AAP) annual meeting in Buenos Aires.

Our team connected with leaders in the field like Dr. Leandro Piedimonte to discuss how Deep TMS™ is expanding treatment possibilities for patients with depression, OCD, and other mental health conditions.

It was inspiring to see the enthusiasm around neuromodulation and the continued growth of innovative mental health solutions across Latin America. We’re excited to build on these conversations and support clinicians in delivering life-changing care around the world. 💡🧠

09/29/2025

🚨 Featured in MassDevice 🚨

BrainsWay has received expanded FDA clearance for our Deep TMS™ system, now including an accelerated treatment protocol for Major Depressive Disorder (MDD) and patients with comorbid anxiety symptoms.

🔹 6 treatment days vs. 4 weeks under the standard protocol
🔹 Each session lasts less than 10 minutes
🔹 Supported by a multicenter, randomized, controlled study
🔹 Comparable efficacy with fewer clinic visits

👉 Read the full MassDevice feature: https://www.brainsway.com/?post_type=news_events&p=14746&preview=true

09/25/2025

A Promising Approach for Tough-to-Treat Depression

For patients who haven’t responded to standard treatments, combining ketamine with Deep Transcranial Magnetic Stimulation (Deep TMS™) may offer new hope.

As Dr. Colleen Hanlon, BrainsWay’s VP of Global Medical Affairs, explained to Healio:

⚡ Ketamine can bring rapid relief, especially for acute symptoms.
🧠 Deep TMS™ builds lasting changes over time, with high response and remission rates that can last months.

Used in sequence — often starting with ketamine and followed by Deep TMS™ — the two treatments may work together to improve outcomes for patients with refractory depression.

Read more about this coordinated approach and Dr. Hanlon’s insights.

https://www.healio.com/news/psychiatry/20250923/coordinated-transcranial-magnetic-stimulation-ketamine-may-benefit-refractory-depression

Transcranial magnetic stimulation and ketamine have been effective in treating depression. But when patients still struggle after using them individually, coordinated treatment offers promise, Colleen A. Hanlon, PhD, told Healio. “You can think of the brain as an organ that’s both chemic...

09/25/2025

The secret to growth is not what you think...

Most TMS clinics focus on generating more leads but the real driver of growth is often overlooked: Patient Experience (PX).

In partnership with one of our preferred marketing partners Rise4, we hosted a webinar diving into how optimizing every step of the patient journey, from first click to first treatment, can dramatically improve conversion, outcomes, and ROI.

We have turned those insights into a practical article:
👉 https://ow.ly/xzY050WYmTR

If you’re a TMS clinic leader looking to grow without increasing ad spend, this is a must-read. Free playbook can be downloaded in the article.

09/24/2025

BrainsWay is proud to exhibit at the 25th World Congress of Psychiatry (WCP 2025) in Prague, October 5–8.

We’ll showcase our groundbreaking Deep TMS™ technology, advancing mental health treatment for depression, OCD, and addictions worldwide.

Join us in Prague to discover how BrainsWay is shaping the future of psychiatry. 💡

09/22/2025

Let’s talk about the facts.

There are many misconceptions about TMS treatment. Join us for a free webinar where Dr. Stefani LaFrenierre will separate fact from fiction and help reframe the conversation around mental health care.

📅 Monday, October 6
🕓 4 PM EDT / 1 PM PDT

✅ Save your spot today: https://ow.ly/FNLe50WXIp3

09/18/2025

The secret to clinic growth might not be what you think...

Most TMS clinics focus on generating more leads but the real driver of growth is often overlooked: Patient Experience (PX).

In partnership with our preferred marketing partner Rise4, we hosted a webinar diving into how optimizing every step of the patient journey—from first click to first treatment—can dramatically improve conversion, outcomes, and ROI.

We have turned those insights into a practical article: https://ow.ly/teEU50WZ05K

If you’re a TMS clinic leader looking to grow without increasing ad spend, this is a must-read.

09/17/2025

Heading to Argentina!
BrainsWay is proud to join the 33rd International Congress on Psychiatry and Mental Health – AAP 2025.
📍 Sheraton Mar del Plata Hotel, Av. Leandro N. Alem 4221, Mar del Plata, Buenos Aires
📌 Booth #14
📅 September 24–26, 2025
We’ll be showcasing how Deep TMS™ is transforming mental health worldwide, from depression and OCD to smoking addiction.

09/16/2025

✨ Breaking News ✨

BrainsWay has officially received FDA clearance for our Accelerated Deep TMS™ protocol to treat Major Depressive Disorder (MDD).

This breakthrough gives patients a faster and non-invasive pathway to relief with no fMRI neuro-navigation required. We are proud to advance the accessibility of mental health care worldwide.

Read the full announcement https://www.brainsway.com/news_events/brainsway-receives-fda-clearance-for-accelerated-deep-tms-protocol-for-non-invasive-treatment-of-major-depressive-disorder-mdd/